Predictive molecular markers in metastases to the central nervous system: recent advances and future avenues
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Predictive molecular markers in metastases to the central nervous system: recent advances and future avenues
Authors
Keywords
Brain metastases, Cancer, Biomarkers, Prediction, Review
Journal
ACTA NEUROPATHOLOGICA
Volume 128, Issue 6, Pages 879-891
Publisher
Springer Nature
Online
2014-10-06
DOI
10.1007/s00401-014-1350-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- National Working Group Meeting on ALK diagnostics in lung cancer
- (2014) Wendy Cooper et al. Asia-Pacific Journal of Clinical Oncology
- Treatment outcomes and prognostic factors for patients with brain metastases from breast cancer of each subtype: a multicenter retrospective analysis
- (2014) Naoki Niikura et al. BREAST CANCER RESEARCH AND TREATMENT
- Noninvasive Diagnosis of Actionable Mutations by Deep Sequencing of Circulating Free DNA in Lung Cancer from Never-Smokers: A Proof-of-Concept Study from BioCAST/IFCT-1002
- (2014) S. Couraud et al. CLINICAL CANCER RESEARCH
- Dramatic Response to Crizotinib in ROS1 Fluorescent In Situ Hybridization- and Immunohistochemistry-Positive Lung Adenocarcinoma: A Case Series
- (2014) Rita Chiari et al. Clinical Lung Cancer
- HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer
- (2014) Eric Van Cutsem et al. Gastric Cancer
- Immunohistochemistry as a screening tool forALKrearrangement in NSCLC: evaluation of five different ALK antibody clones andALKFISH
- (2014) Georg Hutarew et al. HISTOPATHOLOGY
- Tumour-infiltrating lymphocytes and expression of programmed death ligand 1 (PD-L1) in melanoma brain metastases
- (2014) Anna Sophie Berghoff et al. HISTOPATHOLOGY
- Amplification and overexpression ofCMETis a common event in brain metastases of non-small cell lung cancer
- (2014) Matthias Preusser et al. HISTOPATHOLOGY
- ROS1 translocations and amplifications in lung cancer brain metastases
- (2014) Matthias Preusser et al. JOURNAL OF NEURO-ONCOLOGY
- Canadian Anaplastic Lymphoma Kinase Study: A Model for Multicenter Standardization and Optimization of ALK Testing in Lung Cancer
- (2014) Jean-Claude Cutz et al. Journal of Thoracic Oncology
- A Prospective, Molecular Epidemiology Study of EGFR Mutations in Asian Patients with Advanced Non–Small-Cell Lung Cancer of Adenocarcinoma Histology (PIONEER)
- (2014) Yuankai Shi et al. Journal of Thoracic Oncology
- An International Interpretation Study Using the ALK IHC Antibody D5F3 and a Sensitive Detection Kit Demonstrates High Concordance between ALK IHC and ALK FISH and between Evaluators
- (2014) Murry W. Wynes et al. Journal of Thoracic Oncology
- Safety and efficacy of vemurafenib in BRAFV600E and BRAFV600K mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study
- (2014) Grant A McArthur et al. LANCET ONCOLOGY
- Immunotherapy in the treatment of non-small cell lung cancer
- (2014) Raghav Sundar et al. LUNG CANCER
- Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer
- (2014) Cassandra L Hodgkinson et al. NATURE MEDICINE
- Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA
- (2014) Alain R Thierry et al. NATURE MEDICINE
- Current approaches to the treatment of metastatic brain tumours
- (2014) Taofeek K. Owonikoko et al. Nature Reviews Clinical Oncology
- Leptomeningeal metastasis: a Response Assessment in Neuro-Oncology critical review of endpoints and response criteria of published randomized clinical trials
- (2014) M. Chamberlain et al. NEURO-ONCOLOGY
- Reflex ALK immunohistochemistry is feasible and highly specific for ALK gene rearrangements in lung cancer
- (2014) Michelle Houang et al. PATHOLOGY
- BRAF Mutations in Patients with Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
- (2014) Dong Chen et al. PLoS One
- Screening of ROS1 Rearrangements in Lung Adenocarcinoma by Immunohistochemistry and Comparison with ALK Rearrangements
- (2014) Yoon Jin Cha et al. PLoS One
- Gastric cancer†: ESMO–ESSO–ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2014) Tom Waddell et al. RADIOTHERAPY AND ONCOLOGY
- Ultra-sensitive liquid biopsy of circulating extracellular vesicles using ExoScreen
- (2014) Yusuke Yoshioka et al. Nature Communications
- PD-L1 Expression in Triple-Negative Breast Cancer
- (2014) E. A. Mittendorf et al. Cancer Immunology Research
- Data Set for Pathology Reporting of Cutaneous Invasive Melanoma
- (2013) Richard A. Scolyer et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Intrapatient Homogeneity of BRAFV600E Expression in Melanoma
- (2013) Alexander M. Menzies et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Small-cell lung cancer (SCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2013) M. Fruh et al. ANNALS OF ONCOLOGY
- Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2013) M. Stahl et al. ANNALS OF ONCOLOGY
- Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
- (2013) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- Intrathecal administration of trastuzumab for the treatment of meningeal carcinomatosis in HER2-positive metastatic breast cancer: a systematic review and pooled analysis
- (2013) Flora Zagouri et al. BREAST CANCER RESEARCH AND TREATMENT
- A systematic review of trastuzumab and lapatinib in the treatment of women with brain metastases from HER2-positive breast cancer
- (2013) Pia Bükmann Larsen et al. CANCER TREATMENT REVIEWS
- Guidelines for biomarker testing in metastatic melanoma: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology
- (2013) S. Martín-Algarra et al. Clinical & Translational Oncology
- Vemurafenib in patients with BRAFV600 mutation-positive melanoma with symptomatic brain metastases: Final results of an open-label pilot study
- (2013) Reinhard Dummer et al. EUROPEAN JOURNAL OF CANCER
- Malignant Melanoma S3-Guideline “Diagnosis, Therapy and Follow-up of Melanoma”
- (2013) Annette Pflugfelder et al. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT
- Receptor change-clinicopathologic analysis of matched pairs of primary and cerebral metastatic breast cancer
- (2013) C. Bachmann et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
- (2013) Antonio C. Wolff et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial of Erlotinib Plus Concurrent Whole-Brain Radiation Therapy for Patients With Brain Metastases From Non–Small-Cell Lung Cancer
- (2013) James W. Welsh et al. JOURNAL OF CLINICAL ONCOLOGY
- Breast cancer brain metastases responding to primary systemic therapy with T-DM1
- (2013) Rupert Bartsch et al. JOURNAL OF NEURO-ONCOLOGY
- Rapid Response of Brain Metastasis to Crizotinib in a Patient with ALK Rearrangement–Positive Non–Small-Cell Lung Cancer
- (2013) Hiroyasu Kaneda et al. Journal of Thoracic Oncology
- Effective Crizotinib Schedule for Brain Metastases in ALK Rearrangement Metastatic Non–Small-Cell Lung Cancer
- (2013) Nir Peled et al. Journal of Thoracic Oncology
- PET imaging of oestrogen receptors in patients with breast cancer
- (2013) Michel van Kruchten et al. LANCET ONCOLOGY
- Frequency of EGFR and KRAS mutations in patients with non small cell lung cancer by racial background: Do disparities exist?
- (2013) Joshua Bauml et al. LUNG CANCER
- ALK gene translocations and amplifications in brain metastases of non-small cell lung cancer
- (2013) Matthias Preusser et al. LUNG CANCER
- High rate of FGFR1 amplifications in brain metastases of squamous and non-squamous lung cancer
- (2013) Matthias Preusser et al. LUNG CANCER
- Nivolumab plus Ipilimumab in Advanced Melanoma
- (2013) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Discordances in Estrogen Receptor Status, Progesterone Receptor Status, and HER2 Status Between Primary Breast Cancer and Metastasis
- (2013) E. Curtit et al. ONCOLOGIST
- GNAQ and GNA11 mutations in melanocytomas of the central nervous system
- (2012) Rajmohan Murali et al. ACTA NEUROPATHOLOGICA
- Brain metastases: pathobiology and emerging targeted therapies
- (2012) Matthias Preusser et al. ACTA NEUROPATHOLOGICA
- Immunohistochemistry Is Highly Sensitive and Specific for the Detection of V600E BRAF Mutation in Melanoma
- (2012) Georgina V. Long et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2012) S. Peters et al. ANNALS OF ONCOLOGY
- Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2012) R. Dummer et al. ANNALS OF ONCOLOGY
- Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2012) B. Escudier et al. ANNALS OF ONCOLOGY
- ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
- (2012) H. J. Schmoll et al. ANNALS OF ONCOLOGY
- Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2012) F. Cardoso et al. ANNALS OF ONCOLOGY
- HER2/neuGene Amplification and Protein Overexpression in Gastric and Gastroesophageal Junction Adenocarcinoma: A Review of Histopathology, Diagnostic Testing, and Clinical Implications
- (2012) Jaclyn F. Hechtman et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Mutation Profiling and Microsatellite Instability in Stage II and III Colon Cancer: An Assessment of Their Prognostic and Oxaliplatin Predictive Value
- (2012) P. G. Gavin et al. CLINICAL CANCER RESEARCH
- Clinical neuropathology practice news 2-2012: BRAF V600E testing
- (2012) David Capper et al. CLINICAL NEUROPATHOLOGY
- Optimal Management of Brain Metastases from Breast Cancer
- (2012) Rupert Bartsch et al. CNS DRUGS
- Role of EGFR Inhibitors in the Treatment of Central Nervous System Metastases from Non-Small Cell Lung Cancer
- (2012) G. L. Ceresoli CURRENT CANCER DRUG TARGETS
- Brain metastasis
- (2012) Matthias Preusser et al. CURRENT OPINION IN NEUROLOGY
- Trial design on prophylaxis and treatment of brain metastases: Lessons learned from the EORTC Brain Metastases Strategic Meeting 2012
- (2012) Matthias Preusser et al. EUROPEAN JOURNAL OF CANCER
- Molecular Gene Expression Profiling to Predict the Tissue of Origin and Direct Site-Specific Therapy in Patients With Carcinoma of Unknown Primary Site: A Prospective Trial of the Sarah Cannon Research Institute
- (2012) John D. Hainsworth et al. JOURNAL OF CLINICAL ONCOLOGY
- EGFR mutation status in brain metastases of non-small cell lung carcinoma
- (2012) Fanny Burel-Vandenbos et al. JOURNAL OF NEURO-ONCOLOGY
- Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial
- (2012) Georgina V Long et al. LANCET ONCOLOGY
- Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study
- (2012) Thomas Bachelot et al. LANCET ONCOLOGY
- GNA11andN-RASmutations: alternatives for MAPK pathway activating GNAQ mutations in primary melanocytic tumours of the central nervous system
- (2012) M. Gessi et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations
- (2012) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunohistochemical testing of BRAF V600E status in 1,120 tumor tissue samples of patients with brain metastases
- (2011) David Capper et al. ACTA NEUROPATHOLOGICA
- Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody
- (2011) David Capper et al. ACTA NEUROPATHOLOGICA
- Loss of Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Metastatic Sites of HER2-Overexpressing Primary Breast Tumors
- (2011) Naoki Niikura et al. JOURNAL OF CLINICAL ONCOLOGY
- Prospective Study Evaluating the Impact of Tissue Confirmation of Metastatic Disease in Patients With Breast Cancer
- (2011) Eitan Amir et al. JOURNAL OF CLINICAL ONCOLOGY
- Correlation of IHC and FISH for ALK Gene Rearrangement in Non-small Cell Lung Carcinoma: IHC Score Algorithm for FISH
- (2011) Eunhee S. Yi et al. Journal of Thoracic Oncology
- Epidemiology of Brain Metastases
- (2011) Lakshmi Nayak et al. Current Oncology Reports
- Concordance of HER2 in primary tumor and leptomeningeal metastases: now what?
- (2010) Nancy U. Lin BREAST CANCER RESEARCH AND TREATMENT
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- Radiolabeled Cetuximab plus Whole-Brain Irradiation (WBI) for the Treatment of Brain Metastases from Non-Small Cell Lung Cancer (NSCLC)
- (2010) Dirk Rades et al. STRAHLENTHERAPIE UND ONKOLOGIE
- Activating mutations of the GNAQ gene: a frequent event in primary melanocytic neoplasms of the central nervous system
- (2009) Heidi V. N. Küsters-Vandevelde et al. ACTA NEUROPATHOLOGICA
- Concordant HER2 status between metastatic breast cancer cells in CSF and primary breast cancer tissue
- (2009) In Hae Park et al. BREAST CANCER RESEARCH AND TREATMENT
- HER Family Receptor Abnormalities in Lung Cancer Brain Metastases and Corresponding Primary Tumors
- (2009) M. Sun et al. CLINICAL CANCER RESEARCH
- Comparison of epidermal growth factor receptor mutations between primary and corresponding metastatic tumors in tyrosine kinase inhibitor-naive non-small-cell lung cancer
- (2008) C.-H. Gow et al. ANNALS OF ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started